Treatment consists of discontinuation of the precipitating agent. Intravenous dantrum - dantrolene sodium and mannitol - may be used to control the rigidity. Dantrolene is thought to impede calcium release from the sarcoplasmic reticulum to cytosol within skeletal muscle. Thus, it uncouples excitation and contraction.
The patient is cooled. Hyperkalaemia and acidosis is corrected. Any arrhythmias are treated. Prophylaxis entails avoidance of volatile agents or the given cause of the last attack, and pretreatment with dantrolene. For the patient susceptible to malignant hyperpyrexia, this regimen has reduced mortality from more than 70% to about 5%.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.